ACMRACM Research, Inc.

$50.54+27% 1Y

Is the business good?

Watch

More warning than reassurance: 2 of 9 health tests passed, profits without cash flow, and margins compressing.

3 to watch, 1 neutral
Fundamental health (F-score)2 / 9SEC EDGAR · Dec 31, 2025

Weak, deteriorating fundamentals. Nine pass/fail tests of year-over-year health from the filings.

Profits arrive as cash-0.05×derived · Jun 30, 2026

Reports an operating profit but operating cash flow is negative, a red flag. Conversion is worsening vs a year ago.

Margin direction, 3 years−4.8 pts

Operating profit is falling even as sales grow, costs are outrunning the top line.

Where ROE comes from4% ROA

A balanced mix of margins, efficiency, and leverage. ROE 7% = margin × turnover × leverage.

Unless marked, from derived.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF conversionbottom 4% of the market
Leverage (Debt/EBITDA)middle of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is ACMR?

ACM Research, Inc. earns 9.7% on the capital it employs against a 9.0% cost of capital, so the business is worth more the bigger it gets.

9.7%

Return on invested capital · cost of capital 9.0% · 0.67 points above what the capital costs: growth creates value

Operating margin
13%

Operating margin · Semiconductor Equipment & Materials median 10% · 12 months to Q2 2026

Cash conversion
−0.05×

Cash conversion · 0.49× a year ago · the operating profit has not turned into cash yet

Share count, year on year
+6.5%

Share count, year on year · shareholders own a smaller slice than a year ago

Operating margin by fiscal year
YearOperating margin
FY202014%
FY202115%
FY202215%
FY202317%
FY202419%
FY202512%
Details›
Gross margin12 months to Q2 2026
44%
Operating margin12 months to Q2 2026
13%
Net margin12 months to Q2 2026
14%
Free cash flow margin
−11%
R&D as % of revenue
16%
Revenue, trailing twelve months
$1.04B
Free cash flow, trailing twelve months
−$119M
Net income, trailing twelve months
$150M
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
9.7%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.

Customers and suppliers

Who buys from ACMR and who it buys from, as the companies report it.

17%of revenue comes from customer one, the largest of 4 disclosed customers
Customerswho buys
Supplierswho it buys from

None disclosed.

A company has to disclose every customer behind 10% or more of its revenue. Each share comes from the latest annual report of the company that states it and shows on both companies’ pages; ACMR’s own figures are from its FY2025 10-K. Smaller customers and suppliers go unreported.

On our screens:Stocks with no debt